(Q35207625)

7 August 2017

1 reference

title

Current and future trends in the oral pharmacotherapy of male erectile dysfunction (English)

1 reference

7 August 2017

0 references

2

Christian G Stief

1 reference

7 August 2017

3

Udo Jonas

1 reference

7 August 2017

Stefan Uckert

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Expert Opinion on Investigational Drugs

7 August 2017

published in

1 reference

7 August 2017

volume

12

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

1521-1533

1 reference

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxation of human isolated corpus cavernosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Phosphodiesterase 5 inhibitors: current status and potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Expression of different phosphodiesterase genes in human cavernous smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Comparison of FDA reports of patient deaths associated with sildenafil and with injectable alprostadil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Apomorphine in the evaluation of dopaminergic function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Nitric oxide synthase inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Spinal monoaminergic modulation of masculine copulatory behavior in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Serotonin receptor subtypes and sexual behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Guanylate cyclase and the .NO/cGMP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Human recombinant soluble guanylyl cyclase: expression, purification, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Soluble guanylate cyclase: an old therapeutic target re-visited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

NO-independent stimulators of soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

A-350619: a novel activator of soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Neurological risk profile in organic erectile impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Cavernous and systemic plasma levels of norepinephrine and epinephrine during different penile conditions in healthy men and patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Adrenal control of erectile function and nitric oxide synthase in the rat penis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Yawning and penile erection: central dopamine-oxytocin-adrenocorticotropin connection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

The cloning of a family of genes that encode the melanocortin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Growth hormone: a reproductive endocrine-paracrine regulator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Serum levels of human growth hormone during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Effects of human growth hormone in men over 60 years old

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Growth hormone replacement in healthy older men improves body composition but not functional ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Can growth hormone therapy cause diabetes? KIMS Strategic Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

Growth hormone, somatomedins and men's health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.9.1521

10.1517/13543784.12.9.1521

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference